The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration has ...

For new submissions for review, Elsa provides a basis for pre-analysis before the normal reviewers interact with the data, says Jeff Elton of ConcertAI.

The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinformation ...

The FDA launched Elsa, a generative AI tool designed to help employees, including scientific reviewers and investigators, work more efficiently. In a statement, the agency said the tool "modernizes ...